Ignyta Company
%20.jpg)
Ignyta is a scientifically driven biotechnology company catalyzing personalized medicine in autoimmune diseases. Their goals are to revolutionize the quality of biomarkers and tests available to rheumatologists and patients to help them make better informed, more individualized treatment decisions; and to identify truly novel autoimmune disease targets for biopharmaceutical companies to enable the development of precise therapies for patients worldwide.
Investors
Connections from
Funding Status:
M&A
Headquarters:
San Diego, California, United States
Acquisitions Number:
1
Founded Date:
2011-01-01
Employee Number:
101-250
Last Funding Type:
Post-IPO Equity
Total Funding:
$375.5M
Estimated Revenue:
Less than $1M
Industry:
Biotechnology, Health Care, Health Diagnostics
Investors Number:
5
Technology:
P4 Medicine
Investor Type:
For Profit